Mazi Ahlam, Lands Larry C
Division of Pediatric Respiratory Medicine, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
Division of Pediatric Respiratory Medicine, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
Ann Allergy Asthma Immunol. 2014 Oct;113(4):393-7. doi: 10.1016/j.anai.2014.06.024. Epub 2014 Aug 1.
The diagnosis of asthma is based on clinical judgment, history of personal or familial atopy, and testing, typically with a methacholine challenge test (MCT). Guidelines suggest a provocation concentration that caused a decrease in forced expiratory volume in 1 second of 20% (PC20) cutoff of 4 mg/mL for a positive test result.
To investigate the effect of lowering the MCT PC20 cutoff from 8 to 4 mg/mL on the number of positive test results and the distribution of test results.
A retrospective study was conducted at the Montreal Children's Hospital from January 1, 2006, through June 31, 2012, on patients referred by nonrespiratory physicians. A 2-minute tidal breathing dosing protocol was used, and the PC20 was calculated by linear interpolation.
A total of 748 patients were tested using spirometry. A total of 134 (17.9%) had a negative MCT result, and 614 (81.1%) responded at 8 mg/mL or less. A total of 570 patients (92.8% of respondents) responded at a dose of 4 mg/mL or higher (median PC20 of 0.47 mg/mL), with the remainder (7.2% of respondents) responding at a dose between 4 and 8 mg/mL (median PC20 of 6.37 mg/mL). There was no difference in the number of positive test results between the sexes, regardless of cutoff. The sensitivity of MCT was 82.1% at a cutoff of 8 mg/mL and 76.2% at 4 mg/mL. With a pretest likelihood of asthma of 75%, the specificity was 71.2%.
In a standard pediatric referral population, using a PC20 cutoff of 4 mg/mL provided a sensitivity of 76.2%, and only excluded 5.8% of all those referred for suspicion of asthma (7.2% of all test results were ≤8 mg/mL). This finding suggests that a PC20 of 4 mg/mL can reasonably be used as a cutoff for a positive MCT result in children.
哮喘的诊断基于临床判断、个人或家族过敏史以及检测,通常采用乙酰甲胆碱激发试验(MCT)。指南建议,对于阳性检测结果,引起一秒用力呼气量下降20%的激发浓度(PC20)临界值为4mg/mL。
研究将MCT的PC20临界值从8mg/mL降至4mg/mL对阳性检测结果数量和检测结果分布的影响。
对2006年1月1日至2012年6月31日在蒙特利尔儿童医院由非呼吸内科医生转诊的患者进行回顾性研究。采用2分钟潮气呼吸给药方案,并通过线性插值法计算PC20。
共对748例患者进行了肺功能检测。共有134例(17.9%)MCT结果为阴性,614例(81.1%)在8mg/mL及以下有反应。共有570例患者(占有反应者的92.8%)在4mg/mL或更高剂量时有反应(PC20中位数为0.47mg/mL),其余患者(占有反应者的7.2%)在4至8mg/mL之间有反应(PC20中位数为6.37mg/mL)。无论临界值如何,两性之间阳性检测结果的数量均无差异。MCT在临界值为8mg/mL时的敏感性为82.1%,在4mg/mL时为76.2%。在哮喘的预检可能性为75%时,特异性为71.2%。
在标准的儿科转诊人群中,使用4mg/mL的PC20临界值时敏感性为76.2%,仅排除了所有疑似哮喘转诊患者中的5.8%(所有检测结果的7.2%≤8mg/mL)。这一发现表明,4mg/mL的PC20可合理用作儿童MCT阳性结果的临界值。